the injection is once a week Storage: The pill stays at room temperature
CagriSema is a fixed-dose combination therapy comprising two molecules administered together in a single once-weekly subcutaneous injection: semaglutide 2.4 mg, a glucagon-like peptide-1 (GLP-1) receptor agonist already approved for weight management as Wegovy, and cagrilintide 2.4 mg, a long-acting analogue of amylin, a hormone involved in appetite regulation and satiety signalling
Additionally, 66% of people who received the treatment lost at least 10% of their body weight, compared to just 12% of people given a placebo
It is thought to interact with beta-3 adrenergic receptors, which are involved in regulating fat metabolism
& Luiken, J
In addition to HS, PPAR- appears to play an important role in the development of ischemiareperfusion injury in several models, including HS [27, 40], and thiazolidinediones have shown protective effects in this context in kidney, liver, brain, and heart tissues [27, 40, 41]
